La Jolla Institute finds new molecular candidates for treatment of asthma and … – EurekAlert (press release)

La Jolla Institute finds new molecular candidates for treatment of asthma and
EurekAlert (press release)
SAN DIEGO – (December 1, 2011) La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.

View full post on asthma – Google News

La Jolla Institute identifies new therapeutic target for asthma, COPD and … – EurekAlert (press release)

La Jolla Institute identifies new therapeutic target for asthma, COPD and
EurekAlert (press release)
The finding marks Dr. Croft's second major discovery with therapeutic potential for asthma. His previous finding, of a novel molecular mechanism driving lung inflammation, is the basis for a potential asthma treatment now in Phase II human clinical

and more »

View full post on asthma – Google News